All Stories

  1. Biobanking in the era of precision oncology
  2. Neurofibromatosis type I with breast cancer: not only for women!
  3. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
  4. Gastric diffuse large B cell lymphoma presenting as paraneoplastic cerebellar degeneration: Case report and review of literature
  5. Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer
  6. Prevention and management of major side effects of targeted agents in breast cancer
  7. Targeted therapies in breast cancer: are heart and vessels also being targeted?
  8. Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer
  9. Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence
  10. DNA methylation profiling reveals a predominant immune component in breast cancers
  11. Integrate: a new model in collaborative breast cancer research
  12. Beyond trastuzumab: New treatment options for HER2-positive breast cancer
  13. Rituximab in Hodgkin lymphoma: Is the target always a hit?
  14. Polycythemia vera-associated pruritus and its management
  15. Orbital metastasis: a rare presentation of osteosarcoma